How to estimate left ventricular hypertrophy in hypertensive patients

Anadolu Kardiyoloji Dergisi

Volumn 14, Issue 4, 2014, Pages 389-395

  Lovic, Dragan ^a   Erdine, Serap ^b   Burak Çatakoǧlu, Alp ^c  

^a InterMedica   (Serbia)

^b ISTANBUL UNIVERSITY   (Turkey)

^c LIV HOSPITAL   (Turkey)

Author keywords

Arterial hypertension; Cardiovascular events; Left ventricular hypertrophy; Pathophysiology

Indexed keywords

CARDIOVASCULAR MAGNETIC RESONANCE; CARDIOVASCULAR PARAMETERS; CARDIOVASCULAR RISK; CELL STRUCTURE; CORONARY ARTERY; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHY; EXTRACELLULAR MATRIX; HEART LEFT VENTRICLE HYPERTROPHY; HEART LEFT VENTRICLE MASS; HEART MUSCLE CELL; HEMODYNAMICS; HUMAN; HYPERTENSION; META ANALYSIS (TOPIC); PATHOPHYSIOLOGY; PREVALENCE; REVIEW; COMPLICATION;

ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHY; HUMANS; HYPERTENSION; HYPERTROPHY, LEFT VENTRICULAR;

EID: 84903134858     PISSN: 13028723     EISSN: 13080032     Source Type: Journal    
DOI: 10.5152/akd.2014.5115     Document Type: Review

References (49)

1. Rosei EA, Muisan M. Hypertension and left ventricular hypertrophy. European Society of Hypertension Scientific Newsletter 2011; 12: 17-8.
2. Lovic D, Lovic M, Stojanov V, Lovic B, Jakovljevic B. Importance of hypertensive left ventricular hypertrophy. Internist 2010; 2: 137-9.
3. Olivetti G, Giordano G, Corradi D, Melissari M, Lagrasta C, Gambert SR, et al. Gender difference and aging: effects on the human heart. J Am Coll Cardiol 1995; 26: 1068-79.
4. de Simone G, Devereux RB, Daniels SR, Meyer RA. Gender differences in left ventricular growth. Hypertension 1995; 26: 979-83.
5. De Simone G, Devereux RB, Chinali M, Roman MJ, Barac A, Panza JA, et al. Sex differences in obesity-related changes in left ventricular morphology: the Strong Heart Study. J Hypertens 2011; 29: 1431-8.
6. Mancia G, Fagard R, Narkiewicz K, Redon J, Zanchetti A, Böhm M, et al. 2013 ESH/ESC Guidelines for the management of arterial hypertension. Eur Heart J 2013; 34: 2159-219.
7. Cuspidi C, Sala C, Negri F, Mancia G, Morganti A, Italian Society of Hypertension. Prevalence of left-ventricular hypertrophy in hypertension: an update review of echcardiographic studies. J Hum Hypertens 2012; 26: 343-9.
8. Nagulic S. Kardiologija. Institute for Textbooks and Teaching Aids. Beograd 1991.p.89-93.
9. Devereux RB. Hypertensive cardiac hypertrophy. Pathophysiology, Diagnosis and Management. In: Laragh JH, Bruer BM, 2ed edition. Raven Press. New York 1995: 297-9.
10. Waeber B, Feihl F. Stratification of global cardiovascular risk according to the ESH/ESC guidelines. Rev Med Suisse 2007; 3: 1992-4.
11. Shu-xia W, Hao X, Yu-bao Z, Kai S, Chun-yan F, Hu W, et al. Prevalence and risk factors for left ventricular hypertrophy and left ventricular geometric abnormality in the patients with hypertension among Han chinese. Chin Med J 2012; 125: 21-6.
12. Gradman AH, Alfayoumi F. From left ventricular hypertrophy to congestive heart failure: management of hypertensive heart disease. Prog Cardiovasc Dis 2006; 48: 326-41.
13. Muiesan ML, Salvetti M, Rizzoni D, Castellano M, Donato F, Agabiti-Rosei E. Association of change in left ventricular mass with prognosis during long-term antihypertensive treatment. J Hypertens 1995; 13: 1091-5.
14. Vakili B, Okin P, Devereux RB. Prognostic implication of left ventricular hypertrophy. Am Heart J 2001; 141: 334-41.
15. Mortz W, Scheler S, Schwartzkopff B, Strauer BE. Evalution of cardiac damage in hypertension. J Cardiovascular Risk 1995; 2: 16-26.
16. Olivetti G, Cigola E, Maestri R, Lagrasti C, Corradi D, Quaini F. Recent advances in cardiac hypertrophy. Cardiovasc Res 2000; 45: 68-75.
17. Hachamovitch R, Strobeck J. Regression of hypertensive hypertrophy: its role in the prevention of congestive heart failure. Heart Failure 1986; 2: 5-14.
18. Diez J, Laviades C. Monitoring fibrillar colagen turnover in hiper-tensive heart disease. Cardiovasc Res 1997; 35: 202-5.
19. Sega R, Corrao G, Bambelli M, Beltrame L, Facchetti R, Grassi G, et al. Blood pressure variability and organ damage in a general population: results from the PAMELA study. Hypertension 2002; 39: 710-4.
20. Frohlich DE, Gonzalez A, Diez J. Hypertensive left ventricular hypertrophy risk: beyond adaptive cardiomyocyte hypertrophy. J Hypertens 2001; 29: 17-26.
21. Mujumdar VS, Tyagi SC. Temporal regulation of extracellular matrix components in transition from compensatory hypertrophy to decom-pensatory heart failure. J Hypertens 1999; 17: 261-70.
22. Gomes ER, Lara AA, Almeida PW, Guimaraes D, Resende RR, Campagnole-Santos M, et al. Anggiotensin-(1-7) prevents cardio-myocyte pathological remodeling through a nitric oxide/guanosine 3, 5-cyclic monophosphate-dependent pathway. Hypertension 2010; 55: 153-60.
23. Ferrans VJ. Human cardiac hypertrophy: structural aspects. Eur Heart J 1982; 1: 15-27.
24. Inaba S, Iwai M, Furuno M, Kanno H, Senba I, Okayama H, et al. Role of angiotensin-converting enzyme 2 in cardiac hypertrophy induced by nitric oxide synthase inhibition. J Hypertens 2011; 29: 2236-45.
25. Olivetti G, Abbi R, Quaini F, Kajstura J, Cheng W, Nitahara JA, et al. Apoptosis in the failing human heart. N Engl J Med 1997; 336: 1131-41.
26. Kajstura J, Cheng W, Saraugarajan R, Li P, Li B, Nitahara JA, et al. Necrotic and apoptotic myocyte cell death in the aging heart of Fischer 344 rats. Am J Physol 1996; 271: 1215-28.
27. Strauer B, Schuartzkopff B, Mortz W, Vogt M. Coronary vascular changes in the progression and regression on hypertensive heart disease. J Cardiovasc Pharmacol 1991; 18: 20-7.
28. de Simone G, Verdecchia P, Pede S, Gorini M, Maggioni A P. Prognosis of inappropriate left ventricular mass in hypertension: the MAVI study. Hypertension 2002; 40: 470-6.
29. Bombelli M, Facchetti R, Carugo S, Madotto F, Arenare F, Quarti-Trevano F, et al. LVH increases CV risk independently on in-office and out-of office blood pressure values. J Hypertens 2009; 27: 2458-564.
30. Lovic B, Tasic I, Lovic D. Left ventricular hypertrophy in hypertension. Balneoklimatologija 1997; 1: 69-77.
31. Friberg P, Allansdotter-Johnsson D, Ambring A, Ahl R, Arheden H, Framme J, et al. Increased left ventricular mass in obese adolescents. Eur Heart J 2004; 25: 987-92.
32. Szlachcic J. What is the role of silent coronary artery disease and left ventricular hypertrophy in genesis of ventricular arrhythmias in men with essential hypertension. J Am Coll Cardiaol 1992; 19: 803-8.
33. Legedz L, Bricca G, Lantelme P, Rial MO, Champomier P, Vincent M, et al. Insulin resistance and plasma trigliceride level are differently related to cardiac hypertrophy and arterial stiffening in hypertensive subjects. Vasc Health Risk Manag 2006; 2: 485-90.
34. Hall D, Mayosi BM, Rahman TJ, Avery PJ, Watkins HC, Keavney B. Common variation in the CD36 (fatty acid translocase) gene is associated with left ventricular mass. J Hypertens 2011; 29: 690-5.
35. Bacharova L, Estes H, Bang L, Rowlandson I, Schillaci G, Verdecchia P, et al. The first statement of the Working Group on Electrocardiographic Diagnosis of Left Ventricular Hypertrophy. J Electrocardial 2010; 43: 197-9.
36. Tsiachris D, Chrysohoou C, Oikonomou E, Lazaros G, Dimitriadis K, Maragiannis D, et al. Distinct role of electrocardiographic criteria in echocardiographic diagnosis of left ventricular hypertrophy according to age, in the general population: the Ikaria Study. J Hypertens 2011; 29: 1624-32.
37. Devereux R, Casal PN, Kligfield P, Eisenberg RR, Miller D, Campo E, et al. Performance of primary and derived M-mode echocardio-graphic measurements for detection of left ventricular hypertrophy in necropsied subject and in patients with systemic hypertension, mitral regurgitation and dilated cardiomyopathy. Am J Cardiol 1986; 57: 1388-93.
38. Leonetti G, Cuspidi C. The heart and vascular changes in hypertension. J Hypertens Suppl 1995; 13: S29-34.
39. Krumholz HM, Larson M, Levy D. Prognosis of left ventricular geometric patterns in the Framingham Heart Study. J Am Coll Cardiol 1995; 25: 879-84.
40. Myerson SG, Bellenger NG, Pennell DJ. Assessment of left ventricular mass by the cardiovascular magnetic resonance. Hypertension 2002; 39: 750-5.
41. Tsioufis C, Kokkinos P, Macmanus C, Thomopoulos C, Faselis C, Doumas M, et al. Left ventricular hypertrophy as a determinant of renal outcome in patients with high cardiovascular risk. J Hypertens 2010; 28: 2299-308.
42. Koren MJ, Devereux RB, Casale PN, Savage DD, Laragh JH. Relation of left ventricular mass and geometry to morbidity and mortality in uncomplicated essential hypertension. Ann Intern Med 1991; 114: 345-52.
43. Levy D, Garrison RJ, Savage DD, Kannel WB, Castelli WP. Prognostic implications of echocardiographically-determinated left ventricular mass in Framingham Heart Study. N Engl J Med 1990; 322: 1561-6.
44. Casale PN, Devereux R, Milner M, Zullo G, Harshfield GA, Pickering TG, et al. Value of echocardiogaphic measurement of left ventricular mass in predicting cardiovascular morbid events in hypertensive men. Ann Intern Med 1986; 105: 173-8.
45. Andrikou E, Tsioufis C, Thomopoulos C, Andrikou I, Kasiakogias A, Leontsinis I, et al. Left ventricular mass index as a predictor of new-onset microalbuminuria in hypertensive subjects: a prospective study. Am J Hypertens 2012; 25: 1195-201.
46. Muiesan M, Salvetti M, Monteduro C, Bonzi B, Pianni A, Viola S, et al. Left ventricular concentric geometry during treatment adversely affect cardiovascular prognosis in hypertensive patients. Hypertension 2004; 43: 731-8.
47. Gerdts E, Wachtell K, Omvik P, Otterstad JE, Oikarinen L, Boman K, et al. Left atrial size and risk of major cardiovascular events during anti-hypertensive treatment: losartan intervention for endpoint reduction in hypertension trial. Hypertension 2007; 49: 311-6.
48. Verdecchia P, Schillaci G, Borgioni C, Ciucci A, Gattobigio R, Zampi I, et al. Prognostic significance of serial changes in left ventricular mass in essential hypertension. Circulation 1998; 13: 48-54.
49. Brandt MC, Mahfoud F, Reda S, Schirmer SH, Erdmann E, Böhm M, et al. Renal sympathetic denervation reduces left ventricular hypertrophy and improves cardiac function in patients with resistant hypertension. J Am Coll Cardiol 2012; 59: 901-9.